600201 生物股份
已收盘 04-24 15:00:00
资讯
新帖
简况
生物股份（600201）2026年一季报简析：净利润同比增长5.44%，公司应收账款体量较大
证券之星 · 04-24 21:30
生物股份（600201）2026年一季报简析：净利润同比增长5.44%，公司应收账款体量较大
生物股份（600201）披露2026年第一季度报告，4月23日股价下跌1.54%
证券之星 · 04-23 17:41
生物股份（600201）披露2026年第一季度报告，4月23日股价下跌1.54%
图解生物股份年报：第四季度单季净利润同比下降1.07%
证券之星 · 04-23 01:16
图解生物股份年报：第四季度单季净利润同比下降1.07%
每周股票复盘：生物股份（600201）子公司获准生产口蹄疫应急疫苗
证券之星 · 04-12
每周股票复盘：生物股份（600201）子公司获准生产口蹄疫应急疫苗
生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗
智通财经 · 04-07
生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗
每周股票复盘：生物股份（600201）子公司获新兽药注册证
证券之星 · 03-29
每周股票复盘：生物股份（600201）子公司获新兽药注册证
生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%
证券之星 · 03-26
生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%
生物股份(600201.SH)子公司取得新兽药注册证书
智通财经 · 03-26
生物股份(600201.SH)子公司取得新兽药注册证书
异动快报：生物股份（600201）3月23日14点39分触及跌停板
证券之星 · 03-23
异动快报：生物股份（600201）3月23日14点39分触及跌停板
生物股份参投企业 发布首款多智能体桌面管家
证券日报 · 03-19
生物股份参投企业 发布首款多智能体桌面管家
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
证券之星 · 03-18
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%
证券之星 · 02-03
生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%
【机构调研记录】睿远基金调研生物股份
证券之星 · 02-03
【机构调研记录】睿远基金调研生物股份
2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股
证券之星 · 02-02
2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股
每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份
证券之星 · 02-01
每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份
生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%
证券之星 · 01-27
生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%
生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%
证券之星 · 01-27
生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%
海通国际：首次覆盖生物股份给予增持评级，目标价20.7元
证券之星 · 01-20
海通国际：首次覆盖生物股份给予增持评级，目标价20.7元
每周股票复盘：生物股份（600201）大股东首次增持61.46万股
证券之星 · 01-11
每周股票复盘：生物股份（600201）大股东首次增持61.46万股
开源证券：给予生物股份买入评级
证券之星 · 01-08
开源证券：给予生物股份买入评级
加载更多
公司概况
公司名称：
金宇生物技术股份有限公司
所属行业：
医药制造业
上市日期：
1999-01-15
主营业务：
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格：
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":13.84,"timestamp":1777014001000,"preClose":14.08,"halted":0,"volume":19314864,"delay":0,"changeRate":-0.017,"floatShares":1112000000,"shares":1112000000,"eps":0.0938,"marketStatus":"已收盘","change":-0.24,"latestTime":"04-24 15:00:00","open":14.02,"high":14.15,"low":13.8,"amount":269000000,"amplitude":0.0249,"askPrice":13.84,"askSize":182,"bidPrice":13.83,"bidSize":887,"shortable":0,"etf":0,"ttmEps":0.0938,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":5,"adr":0,"adjPreClose":14.08,"symbolType":"stock","openAndCloseTimeList":[[1776994200000,1777001400000],[1777006800000,1777014000000]],"highLimit":15.49,"lowLimit":12.67,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":2.82,"roa":"--","peRate":147.547974,"roe":"1.49%","epsLYR":0.09,"committee":0.662475,"marketValue":15387000000,"turnoverRate":0.0174,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-27。","floatMarketCap":15387000000},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2629384260","title":"生物股份（600201）2026年一季报简析：净利润同比增长5.44%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2629384260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629384260?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:30","pubTimestamp":1777037414,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期生物股份发布2026年一季报。截至本报告期末，公司营业总收入3.46亿元，同比下降1.45%，归母净利润8064.3万元，同比上升5.44%。本报告期生物股份公司应收账款体量较大，当期应收账款占最新年报归母净利润比达694.94%。去年的净利率为6.84%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400063475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629884710","title":"生物股份（600201）披露2026年第一季度报告，4月23日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629884710","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629884710?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:41","pubTimestamp":1776937300,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘，生物股份报收于14.08元，较前一交易日下跌1.54%，最新总市值为156.53亿元。该股当日开盘14.16元，最高14.29元，最低13.93元，成交额达2.99亿元，换手率为1.91%。公司于当日披露《金宇生物技术股份有限公司2026年第一季度报告》。利润总额为96,686,207.01元，同比增长0.75%。经营活动产生的现金流量净额为11,407,954.85元，同比减少56.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300048962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","600201","BK0077","BK0196","BK0185","BK0028","BK0012","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629029199","title":"图解生物股份年报：第四季度单季净利润同比下降1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629029199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629029199?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:16","pubTimestamp":1776878166,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份2025年年报显示，当年度公司主营收入13.96亿元，同比上升11.23%；归母净利润1.0亿元，同比下降8.14%；扣非净利润4974.43万元，同比上升0.52%；其中2025年第四季度，公司单季度主营收入3.54亿元，同比上升24.37%；单季度归母净利润-6120.12万元，同比下降1.07%；单季度扣非净利润-6509.31万元，同比上升32.95%；负债率16.04%，投资收益-202.89万元，财务费用-5006.99万元，毛利率53.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626223911","title":"每周股票复盘：生物股份（600201）子公司获准生产口蹄疫应急疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2626223911","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626223911?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:41","pubTimestamp":1775929270,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，生物股份报收于14.96元，较上周的14.46元上涨3.46%。本周，生物股份4月8日盘中最高价报15.54元。4月7日盘中最低价报14.48元。生物股份当前最新总市值166.32亿元，在动物保健板块市值排名1/10，在两市A股市值排名1232/5196。本周关注点公司公告汇总：子公司获准生产紧急免疫用口蹄疫南非1型疫苗。公司将配合国家防疫政策推进紧急免疫工作，确保疫苗质量。本次疫苗为应急批准，后续取得正式生产批文存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0012","BK0185","BK0046","BK0028","600201","159646","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625935601","title":"生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2625935601","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625935601?lang=zh_cn&edition=full","pubTime":"2026-04-07 16:38","pubTimestamp":1775551128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布公告，公司全资子公司金宇保灵生物药品有限公司(简称“保灵公司”)获准生产紧急免疫用口蹄疫南非1型亚单位疫苗和口蹄疫南非1型灭活疫苗(Re-SAT1/2026株)。南非1型口蹄疫是由南非1型口蹄疫病毒引起的发病急、传播快、危害大的一类急性高度传染性疾病。主要感染牛、羊、猪等动物，南非1型口蹄疫疫苗获批临时生产后，公司将积极配合国家防疫政策，加快推进紧急免疫工作，严格按照相关要求组织生产，确保疫苗质量，保障畜牧业健康稳定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0028","BK0185","BK0012","600201","159646","BK0188","BK0239","BK0046","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623580338","title":"每周股票复盘：生物股份（600201）子公司获新兽药注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623580338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623580338?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:09","pubTimestamp":1774724950,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，生物股份报收于13.96元，较上周的14.6元下跌4.38%。本周，生物股份3月23日盘中最高价报14.37元。本周关注点公司公告汇总：子公司金宇优邦取得鹅新城疫、小鹅瘟二联灭活疫苗新兽药注册证书公司公告汇总生物股份全资子公司金宇优邦生物科技（江苏）有限公司联合研制的鹅新城疫、小鹅瘟二联灭活疫苗获农业农村部批准为新兽药。上市前需申请兽药产品批准文号。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","600201","BK0077","BK0185","BK0028","BK0012","BK0196","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622866378","title":"生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622866378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622866378?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:08","pubTimestamp":1774534101,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，生物股份报收于13.66元，较前一交易日下跌1.44%，最新总市值为151.86亿元。该股当日开盘13.77元，最高13.92元，最低13.55元，成交额达2.15亿元，换手率为1.41%。近日，生物股份发布关于子公司取得新兽药注册证书的公告。该疫苗用于预防鹅新城疫和小鹅瘟，种鹅免疫产生期为二免后21日，免疫期5个月，雏鹅被动免疫期20日。产品需在2～8℃保存，有效期12个月。上市前需申请兽药产品批准文号。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600043903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0077","BK0188","BK0185","BK0196","BK0239","BK0046","600201","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622121832","title":"生物股份(600201.SH)子公司取得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622121832","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622121832?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:04","pubTimestamp":1774512272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)公告，公司全资子公司金宇优邦生物科技(江苏)有限公司(简称“金宇优邦”)与其他单位联合研制的鹅新城疫、小鹅瘟二联灭活疫苗(A-VII株+GPVP3/Bac株)获批准为新兽药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物股份(600201.SH)子公司取得新兽药注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0077","BK0196","BK0012","BK0028","BK0046","BK0188","BK0185","600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621672759","title":"异动快报：生物股份（600201）3月23日14点39分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2621672759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621672759?lang=zh_cn&edition=full","pubTime":"2026-03-23 14:40","pubTimestamp":1774248055,"startTime":"0","endTime":"0","summary":"证券之星3月23日盘中消息，14点39分生物股份（600201）触及跌停板。其所属行业动物保健目前下跌。该股为内蒙古概念，宠物经济，人工智能概念热股。3月20日的资金流向数据方面，主力资金净流出2932.8万元，占总成交额5.64%，游资资金净流入1606.35万元，占总成交额3.09%，散户资金净流入1326.45万元，占总成交额2.55%。近5日资金流向一览见下表：生物股份主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300014989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","BK0188","600201","BK0239","BK0185","BK0196","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620295233","title":"生物股份参投企业 发布首款多智能体桌面管家","url":"https://stock-news.laohu8.com/highlight/detail?id=2620295233","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620295233?lang=zh_cn&edition=full","pubTime":"2026-03-19 06:33","pubTimestamp":1773873180,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 近日，国内动物保健行业的龙头企业金宇生物技术股份有限公司，在人工智能领域的战略布局再结硕果。3月18日，其参投的厦门星宇智算智能科技有限公司正式发布首款多智能体桌面管家——XyClaw。 据了解，生物股份投资星宇智算，为星宇智算的技术研发与产品落地提供了坚实的资本支持。投资者据此操作，风险自担。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-03-19/doc-inhrnktw1039120.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-03-19/doc-inhrnktw1039120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","BK0239","BK0046","BK0196","BK0012","600201","BK0185","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620675239","title":"华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620675239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620675239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:21","pubTimestamp":1773825667,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司持有华兰基因多少比例的股份？华兰生物回复：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800029977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0012","600201","BK0077","BK0046","002007","BK0185","BK0028","BK0197","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608887293","title":"生物股份（600201）披露股东股份解除质押公告，2月3日股价上涨0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608887293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608887293?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:04","pubTimestamp":1770127491,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，生物股份报收于16.42元，较前一交易日上涨0.86%，最新总市值为182.55亿元。近日，金宇生物技术股份有限公司发布公告称，持股5%以上股东内蒙古金宇生物控股有限公司持有公司股份125,510,800股，占公司总股本的11.29%。本次解除质押后，生物控股累计质押公司股份15,820,000股，占其所持股份的12.60%，占公司总股本的1.42%。生物控股及其一致行动人合计持有公司股份154,647,368股，占公司总股本的13.91%；本次解除质押后累计质押股份占其合计持股的10.23%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300042778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0185","BK0012","600201","BK0188","BK0239","BK0046","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608204819","title":"【机构调研记录】睿远基金调研生物股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608204819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608204819?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:13","pubTimestamp":1770077629,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及2月2日披露的机构调研信息，睿远基金近期对1家上市公司进行了调研，相关名单如下：1）生物股份 调研纪要：公司于2025年7月取得非洲猪瘟亚单位疫苗临床批件，10月启动田间试验，2026年1月23日完成首次攻毒试验，计划2026年4月启动第二轮攻毒试验，6月完成临床数据分析并提交报告，争取早日实现产业化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300006756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","600201","BK0028","BK0239","BK0185","BK0046","BK0077","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608085992","title":"2月2日生物股份跌9.81%，国泰中证畜牧养殖ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608085992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608085992?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:31","pubTimestamp":1770021115,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日生物股份跌9.81%，收盘报16.28元，换手率6.66%，成交量74.05万手，成交额12.55亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为国泰基金的国泰中证畜牧养殖ETF。国泰中证畜牧养殖ETF目前规模为59.49亿元，最新净值0.6414，较上一交易日上涨0.25%，近一年上涨16.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0077","BK0046","516670","BK0239","600201","BK0188","BK0196","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608077072","title":"每周股票复盘：生物股份（600201）生物控股质押3.10%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077072","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608077072?lang=zh_cn&edition=full","pubTime":"2026-02-01 02:09","pubTimestamp":1769882950,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，生物股份报收于18.05元，较上周的17.35元上涨4.03%。本周关注点公司公告汇总：股东内蒙古金宇生物控股有限公司质押7,420,000股，占公司总股本3.10%公司公告汇总生物股份关于股东股份质押的公告金宇生物技术股份有限公司股东内蒙古金宇生物控股有限公司持有公司股份125,474,300股，占公司总股本的11.29%。本次质押后累计质押股份数量为34,420,000股，占其所持股份的27.43%，占公司总股本的3.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0077","BK0012","BK0239","600201","BK0046","BK0185","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606623788","title":"生物股份（600201）股东内蒙古金宇生物控股有限公司质押742万股，占总股本0.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623788?lang=zh_cn&edition=full","pubTime":"2026-01-27 18:31","pubTimestamp":1769509872,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份1月27日公开信息显示，股东内蒙古金宇生物控股有限公司向浙商证券股份有限公司合计质押742.0万股，占总股本0.67%。质押详情见下表：截止本公告日，股东内蒙古金宇生物控股有限公司已累计质押股份3442.0万股，占其持股总数的28.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700033089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","BK0077","BK0012","BK0239","600201","BK0046","BK0185","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606020522","title":"生物股份（600201）披露股东股份质押公告，1月27日股价上涨2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606020522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606020522?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:32","pubTimestamp":1769506377,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，生物股份报收于18.5元，较前一交易日上涨2.04%，最新总市值为205.67亿元。该股当日开盘18.26元，最高18.96元，最低17.9元，成交额达11.42亿元，换手率为5.57%。公告显示，公司股东内蒙古金宇生物控股有限公司持有公司股份125,474,300股，占公司总股本的11.29%。本次将其持有的7,420,000股无限售流通股质押给浙商证券股份有限公司，用于融资周转。本次质押后累计质押股份数量为34,420,000股，占其所持股份的27.43%，占公司总股本的3.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700029741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","600201","BK0239","BK0188","BK0012","BK0185","BK0077","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604016157","title":"海通国际：首次覆盖生物股份给予增持评级，目标价20.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604016157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604016157?lang=zh_cn&edition=full","pubTime":"2026-01-20 14:06","pubTimestamp":1768889160,"startTime":"0","endTime":"0","summary":"海通国际证券集团有限公司Yidan Lin近期对生物股份进行研究并发布了研究报告《主业走出谷底，关注非瘟疫苗进展》，首次覆盖生物股份给予增持评级，目标价20.7元。生物股份(600201)本报告导 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260120/c674152985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602354065","title":"每周股票复盘：生物股份（600201）大股东首次增持61.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354065","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602354065?lang=zh_cn&edition=full","pubTime":"2026-01-11 03:12","pubTimestamp":1768072330,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，生物股份报收于17.4元，较上周的15.07元上涨15.46%。本周，生物股份1月9日盘中最高价报17.56元，股价触及近一年最高点。股本股东变化股东增减持1月6日，股东内蒙古金宇生物控股有限公司增持生物股份61.46万股，占公司总股本的0.0553%，成交金额约983.22万元。本次增持为2025年12月24日披露的增持计划的首次实施，计划期间为2025年12月24日至2026年12月23日，拟增持金额5000万元至1亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0196","BK0012","BK0028","BK0077","BK0185","BK0239","BK0188","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601368479","title":"开源证券：给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601368479","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601368479?lang=zh_cn&edition=full","pubTime":"2026-01-08 18:32","pubTimestamp":1767868379,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司陈雪丽,王高展近期对生物股份进行研究并发布了研究报告《公司深度报告：非瘟亚单位疫苗全球首发在即，创新龙头成长动能强劲》，给予生物股份买入评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800032121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777129243852,"stockEarnings":[{"period":"1week","weight":-0.0572},{"period":"1month","weight":-0.0014},{"period":"3month","weight":-0.2023},{"period":"6month","weight":0.2851},{"period":"1year","weight":0.9902},{"period":"ytd","weight":-0.0816}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0377},{"period":"3month","weight":-0.0136},{"period":"6month","weight":0.0328},{"period":"1year","weight":0.2374},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44780人(较上一季度增加3.41%)","perCapita":"24826股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}